Unibest
← Back to patent-cliff list

CAS 103-80-0

2-Phenylacetyl chloride

Codes: LEVO-017, (II)91353-4-a

Application context (from source-drug indications)

Major depressive disorderLevomilnacipran HydrochlorideIschaemic strokeLevomilnacipran HydrochlorideDepressionLevomilnacipran HydrochlorideBack painDiclofenac Sodium/Eperisone HydrochlorideOsteoarthritisDiclofenac SodiumRheumatoid arthritisDiclofenac SodiumAnkylosing spondylitisDiclofenac SodiumCommon bile duct diseaseDiclofenac SodiumDental pulp diseaseDiclofenac SodiumArthritisDiclofenac Sodium

Source drugs (routes using this intermediate)

DrugTierExpiry
Levomilnacipran HydrochlorideTier C — Watch / trade-
Diclofenac Sodium/Eperisone HydrochlorideTier C — Watch / trade-
Diclofenac SodiumTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.